Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 467
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06990776 | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects | ||
| NCT06789289 | A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06008405 | Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy | ||
| NCT06825494 | Clinical Studies for the Treatment of Advanced Solid Tumors | ||
| NCT03754244 | A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics | ||
| NCT05021367 | A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor | ||
| NCT07107256 | Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps | ||
| NCT06700395 | A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma | ||
| NCT01924195 | Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） | ||
| NCT06561607 | A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast Cancer | ||
| NCT06475599 | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer | ||
| NCT05001971 | Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy | ||
| NCT03850873 | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics | ||
| NCT07551427 | A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis | ||
| NCT05192512 | Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT04180150 | A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B | ||
| NCT04805060 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors | ||
| NCT06388759 | TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients | ||
| NCT05982106 | To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects | ||
| NCT01795716 | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body | ||
| NCT04412577 | A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies | ||
| NCT04854681 | Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT06929195 | Clinical Trial to Evaluate the Tolerance of TQB2210 Injection | ||
| NCT03706287 | Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC | ||
| NCT05460481 | Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors | ||
| NCT06116240 | A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors | ||
| NCT03750916 | Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer | ||
| NCT07252908 | A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder | ||
| NCT04895345 | A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma | ||
| NCT06300177 | D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure | ||
| NCT02072031 | Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） | ||
| NCT07512583 | Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors | ||
| NCT04975204 | A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT04398940 | A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer | ||
| NCT01926288 | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B | ||
| NCT03847246 | Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers | ||
| NCT06449859 | A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects | ||
| NCT04964479 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) | ||
| NCT04007835 | Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI | ||
| NCT04923607 | Phase I Clinical Trial of TQC2731 Injection | ||
| NCT06106841 | TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT06507891 | A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets | ||
| NCT05198505 | Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT06297655 | A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A | ||
| NCT04275050 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets | ||
| NCT04675060 | Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules | ||
| NCT07794111 | A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects. | ||
| NCT05985187 | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. | ||
| NCT03825705 | A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma |
